Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Haw ParHAWPF 93 Receivables Turnover is 2.45 as of Dec. 2025. GuruFocus rates HAWPF with a GF Score™ of 93/100 and a GF Value™ of $8.51. The stock has 8 warning signs investors should review. Among 950 Drug Manufacturers companies, Haw Par ranks better than 57.79% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Haw Par's Revenue for the
six
months ended in Dec. 2025 was $80.3 Mil. Haw Par's average Accounts Receivable for the
six
months ended in Dec. 2025 was $32.8 Mil.
Hence, Haw Par's Receivables Turnover for the
six
months ended in Dec. 2025 was 2.45.
Haw Par (OTCPK:HAWPF) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Haw Par Receivables Turnover Related Terms
Haw Par Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Haw Par's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAWPF vs LLY, JNJ, ABBV: Receivables Turnover Comparison
For the Drug Manufacturers - General subindustry, Haw Par's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haw Par Receivables Turnover vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Haw Par's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Haw Par's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haw Par (HAWPF) has a Receivables Turnover of 2.45 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Haw Par and its competitors. According to the industry distribution chart, Haw Par ranks #401 out of 950 companies in the Drug Manufacturers industry, placing it in the top 42.2%.
Is Haw Par's Receivables Turnover too high?
Haw Par's current Receivables Turnover is 2.45. The Drug Manufacturers industry median Receivables Turnover is 5.07. Haw Par's value of 2.45 is 51.7% below this industry median. Based on the distribution chart, Haw Par ranks #401 out of 950 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Haw Par has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Haw Par's Receivables Turnover compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Haw Par ranks #401 out of 950 companies for Receivables Turnover. This puts Haw Par in the upper half of its industry. The industry median Receivables Turnover is 5.07. Haw Par's value of 2.45 is 51.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 950 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haw Par's current Receivables Turnover of 2.45 is 51.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Haw Par and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haw Par's current Receivables Turnover is 2.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haw Par stock overvalued right now?
Haw Par (HAWPF) has a current Receivables Turnover of 2.45. The stock's GF Value™ is $8.51, compared to a current price of $12.00 — trading 41% above its estimated fair value. The current Receivables Turnover is 2.45 and 51.7% below the Drug Manufacturers industry median of 5.07. Haw Par's overall GF Score™ is 93/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Haw Par (HAWPF), the current Receivables Turnover is 2.45 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Haw Par (HAWPF) Overvalued in 2026?
Based on GuruFocus' analysis, Haw Par stock appears to be overvalued.
The current stock price of $12.00 is trading 41% above its estimated GF Value™ of $8.51.
Key valuation signals for HAWPF:
Receivables Turnover: 2.45
GF Value™: $8.51 vs. price of $12.00 (41% above fair value)
Industry Position: 51.7% below the Drug Manufacturers median (#401 of 950)
No single metric tells the full story. See the HAWPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, Property segment, and Leisure segment. The company generates the majority of its revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates key revenue from the other ASEAN and other Asian countries.
93GF Score
Get the complete analysis for HAWPF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAWPF has been successfully added to your 
